blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2589665

EP2589665 - METHOD FOR PREDICTING THERAPEUTIC EFFECT OF IMMUNOTHERAPY ON CANCER PATIENT, AND GENE SET AND KIT TO BE USED IN THE METHOD [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  31.10.2014
Database last updated on 13.07.2024
Most recent event   Tooltip31.10.2014Application deemed to be withdrawnpublished on 03.12.2014  [2014/49]
Applicant(s)For all designated states
Kurume University
67, Asahi-machi Kurume-shi
Fukuoka 8300011 / JP
For all designated states
Kyushu University, National University Corporation
10-1, Hakozaki 6-chome
Higashi-ku
Fukuoka-shi, Fukuoka 812-8581 / JP
For all designated states
Kurume Research Park Co., Ltd.
1-1 Hyakunenkoen
Kurume-shi
Fukuoka 839-0864 / JP
[N/P]
Former [2013/19]For all designated states
Kurume University
67, Asahi-machi Kurume-shi
Fukuoka 8300011 / JP
For all designated states
Kyushu University National University Corporation
6-10-1, Hakozaki Higashi-ku Fukuoka-shi
Fukuoka 812-8581 / JP
For all designated states
Kurume Research Park Co., Ltd.
1-1 Hyakunenkoen Kurume-shi
Fukuoka 839-0864 / JP
Inventor(s)01 / ITOH, Kyogo
c/o Kurume University
67 Asahi-machi
Kurume-shi Fukuoka 830-0011 / JP
02 / NOGUCHI, Masanori
c/o Kurume University
67 Asahi-machi
Kurume-shi Fukuoka 830-0011 / JP
03 / KUHARA, Satoru
c/o Kyushu University
National University Corporation
10-1 Hakozaki 6-chome
Higashi-ku
Fukuoka-shi Fukuoka 812-0053 / JP
04 / YAMADA, Akira
c/o Kurume University
67 Asahi-machi
Kurume-shi Fukuoka 830-0011 / JP
05 / SHICHIJO, Shigeki
c/o Kurume University
67 Asahi-machi
Kurume-shi Fukuoka 830-0011 / JP
06 / KOMATSU, Nobukazu
c/o Kurume University
67 Asahi-machi
Kurume-shi Fukuoka 830-0011 / JP
07 / TASHIRO, Kosuke
c/o Kyushu University
National University Corporation
10-1 Hakozaki 6-chome
Higashi-ku
Fukuoka-shi Fukuoka 812-0053 / JP
 [2013/19]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[N/P]
Former [2013/19]Vossius & Partner
Siebertstrasse 4
81675 München / DE
Application number, filing date11800481.130.03.2011
WO2011JP58094
Priority number, dateJP2010014779729.06.2010         Original published format: JP 2010147797
[2013/19]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2012002011
Date:05.01.2012
Language:JA
[2012/01]
Type: A1 Application with search report 
No.:EP2589665
Date:08.05.2013
Language:EN
[2013/19]
Search report(s)International search report - published on:JP05.01.2012
(Supplementary) European search report - dispatched on:EP23.10.2013
ClassificationIPC:C12Q1/68, C12N15/09, G01N33/53
[2013/19]
CPC:
C12Q1/6886 (EP,US); C12Q1/6837 (US); C12Q1/686 (US);
G01N33/574 (EP,US); C12Q2600/106 (EP,US); C12Q2600/158 (EP,US);
G01N2800/52 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/19]
TitleGerman:VERFAHREN ZUR VORHERSAGE DES THERAPEUTISCHEN EFFEKTS EINER IMMUNTHERAPIE AUF EINEN KREBSPATIENTEN SOWIE IN DEM VERFAHREN VERWENDETER GENSATZ UND -KIT[2013/19]
English:METHOD FOR PREDICTING THERAPEUTIC EFFECT OF IMMUNOTHERAPY ON CANCER PATIENT, AND GENE SET AND KIT TO BE USED IN THE METHOD[2013/19]
French:PROCÉDÉ DE PRÉDICTION DE L'EFFET THÉRAPEUTIQUE D'UNE IMMUNOTHÉRAPIE SUR UN PATIENT CANCÉREUX, ET ENSEMBLE DE GÈNES ET KIT À UTILISER DANS LE PROCÉDÉ[2013/19]
Entry into regional phase29.01.2013Translation filed 
29.01.2013National basic fee paid 
29.01.2013Search fee paid 
29.01.2013Designation fee(s) paid 
29.01.2013Examination fee paid 
Examination procedure02.04.2012Request for preliminary examination filed
International Preliminary Examining Authority: JP
29.01.2013Examination requested  [2013/19]
13.03.2013Amendment by applicant (claims and/or description)
20.05.2014Application deemed to be withdrawn, date of legal effect  [2014/49]
08.07.2014Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2014/49]
Fees paidRenewal fee
22.03.2013Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
31.03.201404   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]US2008076134  (MURACA PATRICK J [US]) [X] 8-12,14,15 * page 7, column 1, paragraph 4 *;
 [I]WO2008086182  (UNIV ROCHESTER [US], et al) [I] 1,5-7,13* page 51 - page 53 *;
 [I]WO2010029174  (GLAXOSMITHKLINE BIOLOG SA [BE], et al) [I] 1,5-7,13 * abstract * * page 7, line 11 - line 17 * * page 14, line 13 - page 17, line 27 *;
 [I]  - REDDISH M A ET AL, "PRE-IMMUNOTHERAPY SERUM CA27.29 (MUC-1) MUCIN LEVEL AND CD69+ LYMPHOCYTES CORRELATE WITH EFFECTS OF THERATOPE SIALYL-TN-KLH CANCER VACCINE IN ACTIVE SPECIFIC IMMUNOTHERAPY", CANCER IMMUNOLOGY AND IMMUNOTHERAPY, SPRINGER-VERLAG, BERLIN, DE, (19960101), vol. 42, no. 5, doi:10.1007/S002620050287, ISSN 0340-7004, pages 303 - 309, XP000914873 [I] 1,5-7,13 * abstract * * page 304; figure 2 * * page 306, column 2 *

DOI:   http://dx.doi.org/10.1007/s002620050287
 [I]  - CELESTIA S. HIGANO ET AL, "Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer", CANCER, (20090815), vol. 115, no. 16, doi:10.1002/cncr.24429, ISSN 0008-543X, pages 3670 - 3679, XP055083505 [I] 1,5-7,13 * abstract * * page 3673 - page 3676; figure 3 *

DOI:   http://dx.doi.org/10.1002/cncr.24429
 [A]  - WHELAN M ET AL, "Biomarkers for development of cancer vaccines", PERSONALIZED MEDICINE 200602 GB, (200602), vol. 3, no. 1, ISSN 1741-0541, pages 79 - 88, XP009173349 [A] 1,5-7,13

DOI:   http://dx.doi.org/10.2217/17410541.3.1.79
 [I]  - WANG XI-DE ET AL, "Identification of candidate predictive and surrogate molecular markers for dasatinib in prostate cancer: rationale for patient selection and efficacy monitoring", GENOME BIOLOGY, BIOMED CENTRAL LTD., LONDON, GB, (20071129), vol. 8, ISSN 1465-6906, page R255, XP021041521 [I] 1,5-7,13 * the whole document *
 [A]  - MOCELLIN S ET AL, "Dissecting tumor responsiveness to immunotherapy: the experience of peptide-based melanoma vaccines", BBA - REVIEWS ON CANCER, ELSEVIER SCIENCE BV, AMSTERDAM, NL, (20031205), vol. 1653, no. 2, doi:10.1016/S0304-419X(03)00032-5, ISSN 0304-419X, pages 61 - 71, XP004475892 [A] 1,5-7,13

DOI:   http://dx.doi.org/10.1016/S0304-419X(03)00032-5
 [AP]  - BARACH Y S ET AL, "T cell coinhibition in prostate cancer: new immune evasion pathways and emerging therapeutics", TRENDS IN MOLECULAR MEDICINE, ELSEVIER CURRENT TRENDS, GB, vol. 17, no. 1, doi:10.1016/J.MOLMED.2010.09.006, ISSN 1471-4914, (20110101), pages 47 - 55, (20110101), XP027594044 [AP] 1,5-7,13 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.molmed.2010.09.006
International search[Y]JP2007037409  (TAIHO PHARMACEUTICAL CO LTD, et al);
 [Y]JP2009509525  (DIGITAL GENOMICS INC.);
 [Y]JP2009532035  (BRISTOL-MYERS SQUIBB CO.);
 [XE]WO2011040532  (UNIV KURUME [JP], et al);
 [X]  - SHI W. ET AL., "Illumina WG-6 BeadChip strips should be normalized separately", BMC BIOINFORMATICS, (2009), vol. 10, no. 372, XP021061900

DOI:   http://dx.doi.org/10.1186/1471-2105-10-372
 [Y]  - MASANORI NOGUCHI, "7. Tailor-Made-gata Peptide Vaccine Ryoho ni yoru Sainen Zenritsusen Gan no Chiryo Seiseki", HINYOKIGEKA, (2008), vol. 21, no. 8, pages 1043 - 1047
by applicantJP2008536094
 JP2010147797
    - YUJIN HOSHIDA, Microarrays for an Integrative Genomics, SPRINGER-VERLAG TOKYO, INC.
    - SUNGWOO KWON ET AL., "DNA Microarray Data Analysis for Cancer Classification Based on Stepwise Discriminant Analysis and Bayesian Decision Theory", GENOME INFORMATICS, (2001), vol. 12, pages 252 - 254
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.